Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01069991 · ClinicalTrials.gov registry record · Phase 2
Asthma Self-Management For Adolescents
A Phase 2 study of Asthma, sponsored by Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 345
- Enrollment target
- 1
- Study location
NCT01069991 is a Phase 2 study of Asthma that has completed, run by Columbia University. The registered enrollment target is 345 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01069991, a Phase 2 study of Asthma, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 345 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to help adolescents with asthma learn to control their illness and live without restrictions. We hypothesize that an intensive school-based asthma education program for students in 9th and 10th grade who have persistent asthma, together with asthma education for their primary care physicians, will improve the students' health status, quality of life, and ability to control their asthma through self-management.
Conditions Studied
Interventions
- BEHAVIORAL Wait list control group
- BEHAVIORAL Patient education group
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 345 participants |
| Start Date | 2002-01 |
| Est. Completion | 2007-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01069991
The ClinicalTrials.gov registry entry for NCT01069991 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 345 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (78% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Wait list control group is the first listed.
NCT01069991 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01069991 about?
NCT01069991 is a clinical study titled "Asthma Self-Management For Adolescents". The goal of this study is to help adolescents with asthma learn to control their illness and live without restrictions. We hypothesize that an intensive school-based asthma education program for students in 9th and 10th grade who have persistent asthma, together with asthma education for their prima...
What is the current status of trial NCT01069991?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 345 participants. The study started on 2002-01. Estimated completion is 2007-02.
What conditions does trial NCT01069991 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01069991?
The interventions under investigation include: Wait list control group (BEHAVIORAL), Patient education group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01069991?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01069991 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.